EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Does treating insomnia with digital cognitive behavioural therapy (Sleepio) mediate improvements in anxiety for those with insomnia and comorbid anxiety? An analysis using individual participant data from two large randomised controlled trials

Alasdair L Henry, Christopher B Miller, Richard Emsley, Bryony Sheaves, Daniel Freeman, Annemarie I Luik, Colin A Espie

Journal of Affective Disorders · 2023

DOI: 10.1016/j.jad.2023.06.053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2023. Verfasst von Alasdair L Henry und 6 weiteren Autor:innen. Beteiligte Einrichtung: Big Health Ltd., London, UK/San Francisco, USA; Sir Jules Thorn Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neuroscie…. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Cognitive Behavioral Therapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health, National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Considerable comorbidity exists between insomnia and anxiety, and evidence shows that the benefits of CBT for insomnia extend to anxiety. Using data from two large trials of digital CBT (dCBT) for insomnia, we evaluated whether improving sleep is an effective treatment target to reduce both insomnia and anxiety symptoms in individuals with insomnia and clinically significant anxiety. METHODS: This was a controlled sub-analysis combining individual participant data from two previous randomised controlled trials of dCBT for insomnia (Sleepio). Participants (N = 2172) with insomnia disorder and clinically significant anxiety symptoms were included in this sub-analysis and received either dCBT or control (usual care or sleep hygiene education). Assessments were evaluated at baseline, post-intervention (week 8 or 10), and follow-up (week 22 or 24). Mediation was evaluated using structural equation models. RESULTS: dCBT for insomnia was superior to control at reducing both insomnia (Hedges' g range = 0.77-0.81; both p < 0.001) and anxiety symptoms (Hedges' g range = 0.39-0.44; both p < 0.001) at all time points. Baseline insomnia symptoms moderated the effects of dCBT on insomnia, however no variables moderated treatment effects on anxiety. Reductions in anxiety symptoms at follow-up were mediated by improvements in sleep at post-intervention (% mediated = 84 %), suggesting a causal pathway. LIMITATIONS: Participants did not have a formal anxiety disorder diagnosis and so the effects of dCBT for insomnia on anxiety may differ by anxiety disorder. CONCLUSIONS: Addressing sleep using dCBT for insomnia may serve as a treatment target from which to improve anxiety in individuals with insomnia and clinically significant comorbid anxiety. CLINICAL TRIAL REGISTRATIONS: Digital Insomnia therapy to Assist your Life as well as your Sleep (DIALS) - ISRCTN60530898 http://www.isrctn.com/ISRCTN60530898. Oxford Access for Students Improving Sleep (OASIS) - ISRCTN61272251 http://www.isrctn.com/ISRCTN61272251.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Initiation and Maintenance DisordersCognitive Behavioral TherapyHumansAnxietyAnxiety DisordersTreatment OutcomeComorbidityRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

AnxietyCBTDigitalInsomniaMediation

Autor:innen und Institutionen

  • Big Health Ltd., London, UK/San Francisco, USA; Sir Jules Thorn Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. Electronic address: alasdair.h…
  • Big Health Ltd., London, UK/San Francisco, USA; Sir Jules Thorn Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Department of Biostatistics and Health Informatics, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
  • Department of Psychiatry, University of Oxford, Oxford, UK; Oxford Health NHS Foundation Trust, Oxford, UK.
  • Department of Psychiatry, University of Oxford, Oxford, UK.
  • Department of Epidemiology, Erasmus MC University Medical Centre, Rotterdam, Netherlands; Trimbos Institute, The Netherlands Institute of Mental Health and Addiction, Utrecht, Netherlands.

Förderung

  • Department of Health
  • National Institute for Health and Care Research

Zitieren

APA

Henry, A. L., Miller, C. B., Emsley, R., Sheaves, B., Freeman, D., Luik, A. I., & Espie, C. A. (2023). Does treating insomnia with digital cognitive behavioural therapy (Sleepio) mediate improvements in anxiety for those with insomnia and comorbid anxiety? An analysis using individual participant data from two large randomised controlled trials. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2023.06.053

Vancouver

Henry AL, Miller CB, Emsley R, Sheaves B, Freeman D, Luik AI, et al. Does treating insomnia with digital cognitive behavioural therapy (Sleepio) mediate improvements in anxiety for those with insomnia and comorbid anxiety? An analysis using individual participant data from two large randomised controlled trials. Journal of Affective Disorders. 2023. doi:10.1016/j.jad.2023.06.053

BibTeX
@article{Henry2023,
  author = {Henry, Alasdair L and Miller, Christopher B and Emsley, Richard and Sheaves, Bryony and Freeman, Daniel and Luik, Annemarie I and Espie, Colin A},
  title = {Does treating insomnia with digital cognitive behavioural therapy (Sleepio) mediate improvements in anxiety for those with insomnia and comorbid anxiety? An analysis using individual participant data from two large randomised controlled trials},
  journal = {Journal of Affective Disorders},
  year = {2023},
  doi = {10.1016/j.jad.2023.06.053}
}
Kostenlos starten →